Mapping myosin light chains by immunoelectron microscopy. Use of anti- fluorescyl antibodies as structural probes by unknown
Mapping Myosin Light Chains by Immunoelectron Microscopy. 
Use of Anti-Fluorescyl Antibodies as Structural Probes 
Tsuyoshi Katoh and Susan Lowey 
Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 02254 
Abstract.  The two classes of light chains in vertebrate 
fast muscle myosin have been selectively labeled with 
the thiol specific reagent 5-(iodoacetamido) fluorescein 
to determine their location in the myosin head.  The 
alkali light chains (A1  and A2) were labeled at a  sin- 
gle cysteine residue near the COOH terminus,  whereas 
the regulatory light chain (LC2) was reacted at either 
cysteine 125 or 154.  The two cysteines of LC2 appear 
to be near each other in the tertiary structure as evi- 
denced by the ease of formation of an intramolecular 
disulfide bond. Besides having favorable spectral prop- 
erties, fluorescein is a potent haptenic immunogen for 
raising high affinity antibodies.  When anti-fluorescyl 
antibodies were added to the fluorescein-labeled light 
chains,  the fluorescence was quenched by >90%, 
thereby providing a  simple method for determining  an 
association constant.  The interaction with antibody 
was the same for light chains exchanged into myosin 
as for free light chains.  Complexes of antibody bound 
to light chain could be visualized in the electron mi- 
croscope by rotary shadowing with platinum.  By this 
approach we have shown that the COOH-terminal 
regions of the two classes of light chains are widely 
separated in myosin: the cysteine residues of LC2 lie 
close to the head/rod junction,  whereas the single cys- 
teine of A1 or A2 is located ,x,90/~ distal to the junc- 
tion.  These sites correspond to the positions of the 
NH~ termini of the light chains mapped in earlier 
studies (Winkelmann,  D.  A., and S, Lowey. 1986. J. 
Mol.  Biol.  188:595-612;  Tokunaga,  M.,  M.  Suzuki, 
K.  Saeki, and T. Wakabayashi.  1987b. J.  Mol.  Biol. 
194:245-255).  We conclude that the two classes of 
light chains do not lie in a  simple colinear arrange- 
ment,  but instead have a more complex organization  in 
distinct regions of the myosin head. 
IGHT chains first attained prominence in the 1970s when 
it was suggested that they regulate the ATPase activity 
of myosin (Dreizen  and Gershman,  1970).  This hy- 
pothesis was reinforced by the advent of SDS-PAGE, which 
showed that myosin from vertebrate fast skeletal muscles had 
a different  light  chain  pattern than that  from slow muscles 
(Lowey and Risby, 1971). Subsequent work involving the for- 
mation of hybrid myosins from fast light chains and cardiac 
heavy chains challenged  this hypothesis by showing that the 
heavy chain  was the principal  determinant  of the level of 
actin-activated  ATPase activity in vertebrate striated muscles 
(Wagner,  1981). The  most compelling evidence against  a 
regulatory role for the light chains  in the active site of ver- 
tebrate skeletal muscle myosin has come from the prepara- 
tion of light chain free-heavy chains which, nevertheless, are 
able to hydrolyze ATP  at  a  reasonable  rate  (Wagner  and 
Giniger,  1981; Sivaramakrishnan  and Burke,  1982). 
Contrary to their obscure role in vertebrate,  striated mus- 
cles, the light chains' contribution to calcium regulation  in 
invertebrate  molluscan (Szent-Gy6rgyi  and Chantler,  1986) 
and in vertebrate smooth muscles (Adelstein and Eisenberg, 
1980) is firmly established.  In scallop myosin, the "regula- 
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tory" or "EDTA-light chain"  is essential  for inhibiting  the 
actin-activated  ATPase  in the absence of calcium, and ac- 
tivating  ATPase  activity upon addition  of calcium (Szent- 
Gy/Srgyi et al.,  1973).  In gizzard  myosin,  phosphorylation 
of a 20,000-D  light chain by a calcium-calmodutin-depen- 
dent kinase is necessary to elevate the actin-activated ATPase 
activity (Sellers  et al.,  1981). 
Despite the absence of a direct connection between light 
chains and enzymatic activity in vertebrate,  skeletal muscles, 
it is possible that light chains may play an important  struc- 
tural role in the mechanism of muscle contraction.  Current 
cross-bridge  models  invoke  a  substantial  conformational 
change within the myosin molecule when it attaches to actin 
during  the contractile  cycle. To account for a power stroke 
of 40--100/~, the distance over which an attached cross-bridge 
develops tension,  the existence of an elastic element within 
the myosin molecule has to be invoked. Two theories are cur- 
rently in vogue regarding  the identity of this extensible ele- 
ment:  one considers the change  to reside primarily in the 
subfragment  1 (S1) region of myosin  (Huxley and Kress, 
1985) and the other proposes a helix-coil  transition  in the 
hinge portion of the myosin rod (Harrington,  1979). The re- 
cent development of an assay for testing myosin-based move- 
ment on actin cables from the alga Nitella has made it possi- 
ble to show that heavy meromyosin which is missing a hinge 
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This finding supports the hypothesis that the head (S1) is the 
principal  domain  for generating  tension  upon  interaction 
with actin.  If that is the case, where in the SI head is the 
site(s) for the elusive conformational change? 
A variety of spectroscopic approaches have been used to 
search for conformational changes in the S1 head, but inde- 
pendent of  whether the label was introduced at the nucleotide 
site or at the reactive SH1 thiol (Cooke et al., 1984), none 
of these experiments provided convincing evidence for head 
rotation. It has been suggested that the region of the myosin 
head containing these labels may be attached to actin in a 
fixed orientation,  and the portion of S1 adjacent to the rod 
may undergo the structural changes associated with the power 
stroke (Huxley et al.,  1983). 
Several studies have mapped the light chains to the "neck 
region" of the myosin head, that portion of the pear-shaped 
head which tapers to the rod (Flicker et al., 1983; Winkel- 
mann et al., 1983; Waller and l.x~ey, 1985). This so-called 
"domain;  consisting of  the two classes of  light chains and the 
COOH terminus of the S1 heavy chain, has been proposed 
for a possible regulatory role in mediating interactions be- 
tween heads in a single molecule, or between heads of  neigh- 
boring molecules in a filament (Vibert et al., 1986). A plau- 
sible extension of this model is to assume that light chain/ 
heavy chain interactions may contribute to the long sought 
for conformational change in the myosin molecule. 
Any mechanism involving the light chains requires  that 
they first be localized along their entire length within the my- 
osin head. Although monoclonal and polyclonal antibodies 
of well-defined  specificities  have been  used  to  map  the 
NH2-terminal regions of both classes of light chains in my- 
osin (reviewed in Winkelmann and Lowey, 1986), the posi- 
tion of their COOH-terminal regions has received less atten- 
tion. The single cysteine residue in the COOH terminus of 
the alkali light chain was localized to the distal region of the 
S1 head by fluorescence energy transfer (Marsh and Lowey, 
1980) and by electron microscopy using an avidin-biotin sys- 
tem (Yamamoto et al., 1985). However, no reports exist on 
the location of the COOH terminus of the regulatory or LC2 
type light chain. 
In this study, we describe methods to independently label 
the two COOH-terminal  cysteine residues in the LC2 light 
chain. A fluorescent reagent (5-[iodoacetamido] fluorescein) 
was chosen  because  of the advantages of a  spectroscopic 
probe; not only do such labels permit energy transfer studies, 
but antibodies against fluorescein haptens have the property 
of  quenching >90% of the emitted signal (Lopatin and Voss, 
1971). By titrating the modified light chain with anti-fluo- 
reseyl antibodies, it was possible to measure the affinity of 
antibody for free as well as for bound light chains. Attempts 
to visualize the antibody/light chain complex by electron mi- 
croscopy are described.  Labeled light chains were also ex- 
changed  into myosin,  and anti-fluorescyl  antibodies  were 
used to localize the fluorescein epitope by immune,  electron 
microscopy. By this approach we have shown that the COOH- 
terminal region of LC2 lies close to the head/rod junction, 
the same  location that earlier studies had assigned to the 
NH2 terminus of the light chain (Winkelmann et al., 1983; 
Tokunaga et al.,  1987b). 
Materials and Methods 
Protein Preparation 
Myosin was prepared from adult White Rock chicken pectoralis muscle ac- 
cording to the method of Margossian and Lowey (1982). Total light chains 
were dissociated from myosin in 6 M guanidine hydrochloride followed by 
ethanol precipitation of the heavy chains (Perrie and Perry,  1970).  Light 
chains were separated by ion exchange chromatography (Holt and Lowey, 
1975), or by ethanol fractionation (Perrie et al., 1973). The latter procedure 
was modified by increasing the ethanol concentration to 26% and allowing 
precipitation to occur during overnight storage at 0*C. The precipitate con- 
sisted mainly of LC2, with only slight contamination by alkali light chains. 
Protein concentration was determined by the method of Bradford (1976) 
using myosin as the standard curve; or by absorhance using the following 
extinction coefficients (1%, 280 nm): 5.0, 6.0, 0.86,  1.06, 11, and 14 for myo- 
sin, LC2, A1, A2, actin, and IgG, respectively.  Molecular weights of 500,000, 
19,000,  20,000,  16,(100, and 150,000  were used for myosin, LC2, AI, A2, 
and IgG, respectively. 
Polyclonal antibody to the amino-terminal regions of A1  (anti-Al) and 
A2 (anti-A2) was prepared according to the procedure of Silberstein and 
Lowey (1981), and kindly provided by G. Waller. The monoclonal antibody 
against LC2 (7C10.2) is described in Winkelmann et al. (1983). Polyclonal 
antibody against fluorescein was prepared according to the method of Lopa- 
tin and Voss (1971), using fluorescein I-keyhole limpet hemocyanin as the 
immunogen. 
Modification of  Light Chains 
The  fluorescent probes N[[(iedoacctyl)amino]cthyl]-5-naphthylamine-l-sul- 
fonic acid  (1,5-IAEDANS) I and 5-(iodacetamido)fluorescein  OAF) were 
purchased from Molecular Probes (Eugene,  OR).  The thiol reagent 5,5'- 
dithio bis (2-nitmbenzoic aeid)(DTNB) was obtained from Sigma Chemical 
Co.,  and 2-nitro-5-thio-cyanobenzoic acid  (NTCB)  was  prepared  as de- 
scribed by Degani and Patchornik (1974). 
The alkali light chains were labeled at their single cysteine residue by 5-IAF 
according to the procedure of Marsh and ISa3wey (1980). Lyophilized LC2 
(freeze-dried from 10 mM NaPi, 2 mg sucrose/mg protein) was incubated 
for 2 h at room temperature in 6 M Gu-HCI, 10 mM DTT, 0.1 M Tris-HCI, 
pH 8.0, to ensure complete reduction of its snlthydryl residues, and then dia- 
lyzed against 0.1 M NaCI, 5 mM Pipes, pH 6.2, for storage. Before labeling 
with fluorophore, LC2 at ~1 mg/ml was dialyzed into 0.1 M NaCI, 2 mM 
EDTA, 20 mM Imidazole, pH 7.0. Reaction was initiated with about a five- 
fold molar excess of 5-IAF or 1,5-IAEDANS in the dark at 0*C, and termi- 
nated by the addition of DTT to a final concentration of 20 mM. Purification 
of labeled light chains was by ion-exchange chromatography:  ,x,15 mg of 
LC2 was applied to a DEAE-Sephacel column (1.5  x  10 cm) equilibrated 
in 0.2 mM DTT, 0.2 mM EDTA, 0.15 M NaP, pH 7.0. Eiution with a lin- 
ear gradient of NaPi up tO 0.4 M  (total volume  =  200 ml) separated the 
modified LC2 into three peaks identified as unlabeled, singly labeled, and 
doubly labeled LC2 light chain. Pooled fractions were dialyzed vs.  1 mM 
DTT,  30  mM  ammonium bicarbonate,  and freeze-dried.  The degree of 
labeling was determined by using an extinction of 5.47 x  10  a M -Tcm -I at 
pH 8.0 and 495 run for fluorescein conjugated to light chain (Marsh and 
Lowey,  1980), and an extinction of 6.0 x  103 M -t cm  -t at 337 run for the 
dansyl group (Hudson and Weber,  1973). 
Cyanylation and cleavage of any unmodified cysteine residues were per- 
~rmed as described by Degani and Patchornik (1974). Fully reduced LC2 
at 0.5 mg/ml was incubated for 1 h in 0.5 mM NTCB, 5 mM NaCN, 0.1 M 
NaCI, 2 mM CaCI2, and 10 mM morpholino propane sulfonic acid (MOPS), 
pH 7.0, at 0°C.Cleavage was carded out at room temperature by raising the 
pH to 9.7 with 0.2 M Na2CO3.  The reaction was terminated by the addition 
of 1 NHCItopH7. 
The reaction of LC2  with  DTNB  was  done by adding an equimolar 
amount of DTNB to 0.2 mg/ml light chain dissolved in 0.1 M NaCI, 2 mM 
EDTA,  5  mM  Pipes,  pH 6.5,  at  150C.  The release of thionitrobenzoate 
(TNB) was monitored at 412 nm using a Perkin-Elmer 552A UV/VIS spec- 
I. Abbreviations  used in this paper: DTNB, 5,5'-dithio his (2-nitrobenzoic 
acid);  IAF,  5-(iodoacetamido)  fluorescein;  1,5-IAEDANS,  N[[(Iodoace- 
tyl)arnino]ethyl]-5-naphthylamine-l-sulfonic  acid;  NTCB,  2-nitro-5-thio- 
cyanobenzoic acid; TNB, thionitrobenzoate. 
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extinction coefficient of 1.3  x  104 M -~ cm  -t (Ellman,  1958). 
The  5-(2-hydroxyethyl)thioacetamido-fluorescein conjugate (FI.SCH2- 
CH2OH) was prepared by reacting 2 mM 5-IAF in 0.1  M  NaCI, 40 mM 
Tris-HCl, pH 8.0, with 0.14 M 2-mercaptoethanol at room temperature in 
the dark for 30 min. The compound was purified by passage through a 
Sephadex G10 column equilibrated with the above buffer. 
Light chain labeled with fluorescein at Cys 154 was prepared by reacting 
DNS-LC2 (light chain singly labeled with the dansyl group, see above) with 
a  10-fold molar excess of 5-IAF in 80 mM NaCI, 2 mM CaCI2,  40 mM 
Tris-HCl, pH 8, at 0°C in the dark. After 2 h, the reaction was terminated 
by adding DTT to 20 mM. Excess reagent and iodide were removed by pas- 
sage through a Sephadex G25 (fine) column. 
Exchange of  Light Chains into Myosin 
Alkali light chains were incorporated into myosin by a minor modification 
of  the method of  Wagner and Weeds (1977); myosin precipitated at low ionic 
strength ("o5 mg/ml) was added to a solution containing 10- to 20-fold molar 
excess of labeled A1 or A2 over myosin, 4.7 M NI-hCI,  12 mM EDTA, 2 
mM DTT,  pH 8, adjusted by Tris. Solid NH4CI was added to saturation at 
0°C, and the solution was gently stirred for 90 min at 0*C. The reaction 
was terminated by the addition of 20 mM MgCI2 and 4 vol of 3 mM MgCI2, 
2 mM DTT, 0.5 M NaCI, 40 mM Tris-HCl, pH 8.0. Myosin was precipitated 
by ammonium sulfate at 50% saturation, and redissolved in a small volume 
of the above buffer.  Although little free light chain remained at this stage, 
the myosin was further purified by gel filtration through a  Sepharose 6B 
column to remove any last traces. In general, 40-50%  exchange occurred 
as determined by gel electrophoresis and absorbance of the labeled species. 
Regulatory (LC2) light chain can be exchanged into myosin at elevated 
temperatures in the presence of EDTA (Wikman-Coffelt et al., 1979).  Myo- 
sin (2 mg/ml) and 1.5 mg/ml labeled LC2 (20-fold molar excess over myo- 
sin) were incubated at varying temperatures in 0.5 M  NaCI, 2 mM DTT, 
2 mM EDTA, 5 mM ATE 40 mM Tris-HCl, pH 8.0 (at 25°C) for 15 min 
with gentle stirring under nitrogen in the dark. The reaction was terminated 
by the addition of MgC12 to a final concentration of 10 mM and cooled on 
ice. The cold solution was diluted 20-fold with 1 mM MgCI2, 5 mM Pipes, 
pH 6.2, and the precipitate was collected by centrifugation. The myosin was 
resuspended in salt, and the precipitation step repeated to remove any traces 
of free light chain. 
ATPase Measurements 
The K+/EDTA and Ca2+-ATPase activity of myosin were measured in 0.5 M 
KCI, 2 mM ATE 40 mM Tris-HC1,  pH 8.0, with 2  mM EDTA added to 
the former, and 5  mM CaCI2  added to the latter ATPase at 25°C.  The 
actin-activated Mg-ATPase activity was determined in 50 mM NaCI, 1 mM 
DTT, 4 mM MgCI2,  2 mM ATE 20 mM Tris-HCl, pH 8.0, at concentra- 
tions of 0.1 t~M myosin and 6 t~M actin, 25°C. Phosphate release was mea- 
sured by the colorimetric method of White (1982). 
Gel Electrophoresis 
Myosin  light chains  were analyzed by  SDS  gel electrophoresis by  the 
method  of  Laemmli  (1970).  Labeled  light  chains  were  separated  on 
urea/acrylamide gels essentially by the method of Perrie and Perry (1970). 
The running gel contained 8 M urea, 8% acrylamide, 0.27% bisacrylamide; 
the acrylamide concentration was reduced to 3.5% in the stacking gel, but 
the acrylamide/bisacrylamide ratio was kept at 30:1.  The running and gel 
buffers were 20 mM Tris/glycine, pH 8.8. The samples were applied in 8 M 
urea, 20 mM Tris/glycine, pH 8.8, 0.1% 2-mercaptoethanol. 
Protein band intensities were determined by densitometry using an EC 
Densitometer connected to a  Hewlett-Packard Recording Integrator. 
Fluorescence Spectroscopy 
Fluorescence measurements were performed with a Perkin-Elmer MPF 44 
instrument equipped with a  thermostated cell housing.  Emission spectra 
were obtained by excitation at 495 nm. Conditions used were 2--400 nM 
fluorescein-labeled light chains, 0.1  mg/ml BSA, 0.1 or (~5 N NaCI, and 
40 mM Tris-HCl, pH 8.0. After each addition of anti-fluorescyl IgG, the 
change in fluorescence intensity was monitored at 520 nm. Degree of bind- 
ing and concentration of free antibody sites were calculated from the titra- 
tion data by assuming a linear relationship between degree of quenching and 
amount of fluorescein bound to lgG. 
lmmunoelectron  Microscopy 
Electron microscopy was performed on a Philips EM301  electron micro- 
scope operated at 60 kV. Light chain- (or myosin) antibody complexes were 
rotary shadowed with platinum as described by Tyler and Branton (1980). 
Labeled light chains (or myosin) and antibodies were mixed at 'M:I molar 
ratio in 0.1 M (or 0.5 M) NaCI, 40 mM Tris-HCl, pH 8.0, at a concentration 
of 3-20 t~M light chain (or 1/~M myosin), and left on ice for several hours. 
Samples were diluted ,~100-fold in 70% glycerol, 0.3 M ammonium acetate, 
pH 7.2,  immediately before spraying onto mica, as described in Winkel- 
mann et al.  (1983). 
Results 
Myosin  from  fast-twitch  skeletal  muscles  contains  two 
classes of low molecular weight subunits: two moles of  alkali 
(A1/A2) light chains and two moles of regulatory (LC2) light 
chains (see review by Lowey, 1986). The major difference 
between the A1 and A2 light chains lies in the additional 41 
NH2-terminal residues  in A1, although  there are also five 
amino acid replacements  in the NH2 terminus of A2 rela- 
tive to the corresponding  sequence in A1 (Fig. 1). The two 
proteins  are identical  in sequence  over the remaining  141 
COOH-terminal  residues.  Polyclonal  antibodies  (anti-A1 
and anti-A2) specific for the NHE-terminal regions of the 
alkali light chains have been isolated (Silberstein and Lowey, 
1981) and used to localize the light chains in myosin by elec- 
tron microscopy (Waller and Lowey, 1985). A monoclonal 
antibody  specific for an epitope in the NH2-terminal third 
of LC2 has been used to localize the regulatory light chain 
in myosin (Winkelmann et al., 1983) (Fig. I). No antibodies 
specific for epitopes in the COOH-terminal  regions of the 
light chains have been prepared to date. As an alternative ap- 
proach to preparing anti-peptide antibodies against this por- 
tion of the sequence, we chose instead to chemically modify 
cysteine residues near the COOH terminus with a haptenic 
group against which antibodies could easily be raised. 
Reaction of  Fluorescein-labeled Alkali Light Chains 
with Anti-Fluorescyl Antibodies 
The single cysteine residue in A1 (Cys 177) and A2 (Cys 136) 
was labeled with 5-IAF as described by Marsh and Lowey 
(1980). The degree of labeling was estimated spectropho- 
tometrically  as  "~0.8 mol fluorescein  per mol  alkali  light 
chain. The interaction between the labeled light chains and 
anti-fluorescyl antibodies could be monitored by observing 
the decrease in extrinsic fluorescence intensity upon the bind- 
ing of antibody to fluorescein.  After each addition of anti- 
body, the emission spectrum was recorded until a maximum 
quenching of '~90% was obtained. This procedure is essen- 
tially the same as that originally  reported by Lopatin and 
Voss (1971) in their studies of the combining site of antibod- 
ies. By plotting the decrease in fluorescence intensity at 520 
nm as a function of added antibody, a maximum value of 
'~0.9 mol IgG combining site per mol bound fluorescein was 
obtained, in agreement with the expected stoichiometry. No 
fluorescence quenching was observed with nonimmune IgG 
(Fig. 2 A). By using lower concentrations of  light chains, the 
amount of free and bound IgG could be determined at each 
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Figure l. Schematic diagram ofAl, A2, and LC2 light chains. The 
regions in the sequence containing the epitopes for the polyclonal 
antibodies, anti-Al and anti-A2,  are indicated, as well as the epi- 
tope in LC2 for the monoclonal antibody (7(210). The position of 
the single cysteine residue in the alkali light chains, and the two cys- 
teines in the regulatory light chain (LC2) are shown. The number- 
ing system is according to Matsuda (1983), and should be increased 
by one to account for the blocked NH2-terminal amino acid which 
has been shown to be c~-N-trimethylalanine  in A1 and LC2 (Henry 
et al.,  1985). 
concentration of added antibody, and the data fitted by a curve 
with an apparent dissociation constant of 2.5 nM (Fig. 2 B 
and Table I). 
The affinity of anti-fluorescyl antibodies for fluorescein 
was ,u40-fold greater than the affinity of anti-light chain an- 
tibodies for epitopes in the NH2 terminus of the light chains 
(data not shown). This strong binding has been ascribed to 
the size, aromaticity and dianionic nature of the fluorophore 
(Kranz et al., 1982). The light chain to which the fluorescein 
was covalently bound had little effect on the interaction, as 
indicated by a similar Ka for protein-free fluorescein. More- 
over, the simultaneous presence of anti-light chain antibod- 
ies did not interfere with the binding of anti-fluorescyl IgG 
to the labeled light chain (data not shown). In fact, the fluo- 
rescyl group interacted freely with the homologous antibod- 
ies even when the labeled light chain was associated with the 
heavy chain in myosin. Apparently, the fluorescyl moiety is 
fully exposed and reactive under all conditions, a property 
ideally suited for its role in forming a  strong antigen/anti- 
body complex for direct visualization in the electron micro- 
scope. 
Labeling of Regulatory Light Chains with Fluorescein 
The labeling of LC2 with 5-IAF was  complicated by the 
presence of two cysteine residues at positions 125 and 154 in 
the sequence (Fig. 1). It was not known whether either of the 
cysteine residues could be labeled selectively. The extent of 
the reaction with IAF was followed electropboretically by 
taking advantage of the two charged groups on fluorescein at 
pH >8. Native, singly and doubly labeled light chains were 
readily separated by urea-PAGE (Fig. 3). As the native LC2 
band disappeared, two faster migrating (fluorescent) bands 
appeared  with  time.  By  measuring  the  intensity  of each 
band, the course of the reaction could be plotted as shown 
in Fig. 3. The initial rate of appearance of the band of inter- 
mediate mobility was  "~10 times greater than  that of the 
fastest  migrating  band,  suggesting  that  the  two  cysteine 
residues have different re,  activities. 
To  identify  the  chemical  modification  in  each  elec- 
trophoretic band, the reaction was terminated at 30 rain and 
the  mixture was  fractionated into three distinct peaks  by 
DEAE-Sephacel ion-exchange chromatography (see Mate- 
rials and Methods). Spectroscopic analysis of the peaks con- 
firmed that the bands of intermediate and fastest mobility 
were singly and doubly labeled LC2, respectively. The ques- 
tion of whether Cys 125 or Cys 154 was the fast reacting thiol 
was resolved by cyanylation and cleavage at the unlabeled 
cysteine  residue  as  described by  Degani  and  Patchornik 
(1974). 
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Figure 2.  Titration of fluorescein-labeled alkali  light chains  by 
anti-fluorescyl antibodies. (A) 0.44 FM FI-AI (FIIAI = 0.84) (o), 
and 0.44 #M FI-A2 (FI/A2 = 0.80) (e) were titrated with specific 
antibody or nonimmune IgG (hi), and the drop in fluorescence 
intensity monitored at 520  nm.  (B) The concentration of light 
chains was reduced to 4.3 nM FI-AI (O),  and 3.4 nM FI-A2 (e) 
and the concentration of anti-fluorescyl antibody ranged from 0.2 
to 100 nM. Solvent conditions were 0.1 mg/ml BSA, 0.5 M NaCI, 
40 mM Tris-HCl, pH 8.0, 20°C. The solid and dotted lines repre- 
sent theoretical binding curves with a dissociation constant of 2.5 
nM, and maximum binding of 0.87 and 0.93 tool lgG site/mol FI, 
respectively. 
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Fluorescein-labeled Light Chains 
Fluorescein-labeled  Dissociation  Maximal 
light chain  constant*  binding~  t 
nM 
Free LC 
AI  (cys  177)  3  0.87 
A2 (cys  136)  3  0.93 
LC2  (cys  125)  8  1.25 
LC2  (cys  154)§  3  0.98 
Bound to  MHC 
A1 (Cys 177)  3  0.82 
A2 (Cys 136)  3  0.75 
LC2  (Cys  125)  5  1.10 
LC2  (Cys  154)§  4  0.98 
FL-SCH2CH2OH  4  1.05 
* Solvent conditions: 0.5 M NaCI, 0.1 mg/ml BSA, 2 mM DTT, 40 mM Tris- 
HCI, pH 8.0, at 20°C. Dissociation constants were estimated assuming first- 
order binding. The constants were reduced "~10-fold  in 0.1  M  NaCI. 
¢ Expressed as mole binding site per mole fluorescyl group. 
§ Cys 125 of this derivative was blocked by  1,5-IAEDANS. 
The  singly  labeled  LC2  light  chain  was  cyanylated by 
NTCB to an extent of 0.86 mol SH/mol LC2 as compared to 
a  value of 1.9  mol SH/mol LC2 for the unmodified light 
chain. The reaction can be conveniently followed at 412 nm 
by measuring the release of TNB which accompanies cyany- 
lation. Cleavage of the cyanylated cysteine is achieved by in- 
cubation at alkaline conditions (pH •10)  for 24 to 72 h at 
room temperature (Fig. 4). SDS polyacrylamide gels showed 
a  17-kD and a  13-kD doublet for the unlabeled LC2 (Fig. 4, 
lane 3), and a 17-kD doublet for the singly labeled LC2 (lane 
Figure 3. Reaction of regulatory light chain with 5-IAE  LC2 (0.6 
mg/ml) and 0.33 mM 5-IAF were incubated in 0.1 M NaCI, 20 mM 
imidazole, pH 7.0, at 0°C. At fixed time intervals, 50 #1 were with- 
drawn and mixed with 2 #1 of 1 M DTT and 0.2 M EDTA to stop 
the reaction. After adding solid urea to 8 M, the samples were run 
on 8% acrylamide urea gels as shown in the inset. Intensity is plot- 
ted as a function of reaction time for the first (o), second (o), and 
third (zx) bands from the top of the gel. The latter two bands were 
fluorescent. 
5). On the basis of their appararent molecular masses, the 
17-kD band would result from cleavage at Cys 154, and the 
13-kD band from cleavage at Cys 125. Since the labeled light 
chain only gave a band(s) in the 17-kD range, which more- 
over was fluorescent (lane 5'), we concluded that Cys  125 
was the thiol labeled with 5-IAE When a different thiol-spe- 
cified fluorophore was used, namely 1,5-IAEDANS, similar 
rapid labeling of Cys  125 was observed. 
To modify Cys 154 selectively, we originally planned to 
reversibly block the fast reacting Cys 125 with DTNB, react 
Cys 154 with IAF, and then reduce Cys 125 with DTT. How- 
ever, when LC2 was reacted with DTNB at the molar ratio 
of  1  mol  DTNB/mol  LC2,  1.7  mol  TNB/mol  LC2  was 
released instead of the expected 1 mol TNB (Fig. 5). The re- 
lease of 2 mol of TNB could only occur by intra- or inter- 
molecular disulfide formation (Ellman, 1959). Examination 
of the  reaction  products  by  SDS-PAGE  showed  a  faster 
migrating species at a time point (15 min) in the plateau re- 
gion of  the reaction, but no evidence of any dimer formation. 
This fast migrating band could readily be reversed to native 
LC2 by DTT, suggesting that its anomalous migration was 
due to an intramolecular disulfide bond.  Since it proved to 
be  difficult to  block  Cys  125  by  this  approach,  we  first 
reacted it with  1,5-IAEDANS, and then modified Cys  154 
with 5-IAF. Light chains thus modified at different cysteine 
residues by two different fluorophores could be separated by 
ion-exchange chromatography, and were shown to have dis- 
tinct mobilities on urea-polyacrylamide  gels (data not shown). 
Visualization of  Antibody~Light Chain Complexes by 
Electron Microscopy 
LC2 light chains labeled at cysteine residue 125 or 154, as 
described above, were titrated with anti-fluorescyl antibod- 
ies by the procedure described for labeled alkali light chains. 
Apparent dissociation constants of 3-8 nM were obtained, 
which is  in a  range comparable to those observed for the 
fluorescein-labeled alkali light chains (Table I). 
The  strong  interaction observed between both types of 
light chains and anti-fluorescyl antibodies suggested that it 
might be feasible to visualize this complex by electron mi- 
croscopy. Light chains alone are too small to show any dis- 
tinct features by metal shadowing (data not shown); however, 
it was thought that by fixing one end with the larger antibody 
molecule, more structural  information might be obtained. 
Unfortunately, this did not prove to be the case; antibody/ 
light chain complexes usually showed only small wispy struc- 
tures emanating from the F~b arms of the triangular-shaped 
IgG (Fig. 6, b, c, and e). Occasionally, a more globular struc- 
ture could be seen at the corners of the antibody molecule 
(Fig. 6f). Aggregates of antibodies were rarely seen, except 
for the anti-A1/A1  complex (Fig. 6 a).  This polyclonal an- 
tibody is specific for a  region of the A1  light chain which 
probably includes several epitopes by virtue of spanning 49 
residues (Fig.  1). Multivalency of antigens (e.g., A1) is re- 
sponsible for antibody/antigen aggregates in that each anti- 
gen is bound to more than one antibody molecule. A similar 
effect is obtained by adding two different antibodies simul- 
taneously to the fluorescein-labeled light chain; one specific 
for the NH2 terminus  (anti-LC2 or anti-A2)  and one for 
the COOH-terminus (anti-fluorescyl IgG) (Fig. 6, d and g). 
Thin connecting links between antibodies were seen in some 
of these images, but no consistent lengths could be measured. 
Katoh and Lowey Mapping the L4"ght Chains of Myosin  1553 Figure 4. SDS gels (15% acrylamide) showing prod- 
ucts of cyanylation followed by cleavage of regulatory 
light chain.  Lane  1,  total  light chains;  lane 2,  un- 
modified  LC2;  lane  3,  cleavage products  of native 
LC2 after 24 h reaction show primarily a doublet at 
•13  kD and a minor doublet at ,x,17 kD (see Materials 
and Methods); lane 4, fluorescein-labeled LC2 (,'~1.3 
F1/LC2); lane 5, cleavage products of modified LC2 
after 72 h show only the higher molecular mass dou- 
blet. Lanes 4' and 5' show the bands visualized in UV 
light before staining. 
Although these observations favor a more compact structure 
for the light chains than the 100-/~-long ellipsoid suggested 
by hydrodynamic studies (Stafford and Szent-Gy6rgyi, 1978; 
Alexis and Gratzer, 1978), the molecules are too small in size 
to permit any firm conclusions. 
Exchange of  Labeled Light Chains into Myosin 
L2 light chain that had been singly or doubly labeled with 
fluorophore was exchanged into myosin at increasing tem- 
peratures in the presence of EDTA (Table II). The extent of 
exchange was estimated by comparing the intensities of the 
labeled and unlabeled LC2 bands on urea gels. As much as 
80 % exchange could be attained for the singly labeled LC2 
by 40°C;  higher temperatures were not feasible because of 
a loss of alkali light chains with accompanying denaturation. 
The native state of the exchanged myosin was demonstrated 
by the relative constancy of the different ATPase activities up 
to 40°C  (Table II). 
The singly labeled alkali light chains were exchanged into 
myosin in  4.7  M  ammonium chloride  according  to estab- 
lished procedures (Wagner and Weeds,  1977).  About 80% 
of the Ca  :÷- and K+/EDTA-activated ATPase activities were 
retained. 
The  attinity  of anti-fluorescyl antibodies  for the  bound 
light chains was measured by fluorescence quenching as de- 
scribed for the free light chains (see Fig. 2).  The apparent 
dissociation constants obtained by this method were approxi- 
Figure 5. Time course of  the reac- 
tion of regulatory light chain with 
equimolar DTNB. LC2 (12.1 #M) 
was reacted with 12.1 #M DTNB 
in  0.1  M  NaCI,  2  mM  EDTA, 
5 mM  Pipes,  pH  6.5, at  15°C. 
The  reaction  was  monitored  by 
the absorbance at 412 nm. The in- 
set  shows the  SDS  gel  (17.5% 
acrylamide) pattern of  the reaction 
products  at the  indicated  times. 
The reaction  was terminated  by 
the  addition  of NEM  and  Tris- 
HC1, except for the  16-min time 
point where [YI'T was added. 
The Journal of Cell Biology, Volume 109, 1989  1554 Figure 6. Gallery of electron micrographs of fluorescein-labeled  light chains complexed  with antibodies  specific for the hapten or for the 
amino-terminal region of the light chain. A, FI-A1 and anti-Al IgG. The presence of antibody aggregates  implies  more than one epitope 
on AI. B, FI-A2 and anti-A2 IgG. The existence  of only monomeric antibody suggests that A2 has a single epitope.  C, FI-A2 and anti- 
fluoreseyl IgG. D, FI-A2 reacted with both anti-A2 and anti-fluorescyl IgG. The aggregates here are a consequence of  two classes of  antibod- 
ies reacting with two different  sites on the light chain: the epitope at the NH2 terminus and the fluorescein  on Cys 136 (see Fig.  1). E, 
FI-LC2 and anti-LC2 (7C10). F, FI-LC2 and anti-fluorescyl IgG. G, F1-LC2 reacted  with both anti-LC2 (7C10) and anti-fluorescyl IgG. 
The last column on the right in A-C and E-F shows antibody in the absence of added light chain. The arrows point to the bound light 
chain.  Bar,  50 nm. 
mately the same as those determined for the free light chains, 
suggesting that the accessibility of the fluorescyl group was 
not altered by the presence of the heavy chains (see Table I). 
Table II. Exchange of  Fluorescyl-labeled  LC2 into Myosin 
ATPase activities (s  -~) 
Temperature  Percent 
Residue labeled*  (°C)  exchange  AM  Ca  2+  K+/EDTA 
Myosin control  25  0  4.4  3.8  16.5 
Cys 125  25  7  4.8  4.0  16.8 
30  26  4.6  4.3  17.8 
35  49  3.1  3.0  13.3 
40  84  3.6  3.9  17.1 
Myosin control  25  0  5.4  4.2  16.5 
Cys 125/154  35  51  4.6  4.0  15.5 
40  72  4.4  3.9  15.1 
45  89  1.1  1.5  6.5 
Myosin control  25  0  4.2  3.2  13.7 
Cys 154*  40  56  3.2  3.0  14.1 
* Exchange was done using a 20-fold molar excess of labeled LC2 over myo- 
sin; solvent  conditions:  0.5 M NaCI, 2 mM EDTA, 2 mM DTT, 5 mM ATP, 
40 mM Tris-HCl, pH 8.0. 
:~ Cys 125 of this derivative was blocked by 1,5-IAEDANS. 
Visualization of  Myosin/Antibody Complexes by 
Electron Microscopy 
Anti-fluorescyl antibodies complexed to myosin were rotary 
shadowed with platinum and examined in the electron micro- 
scope. A high proportion of myosin molecules showed anti- 
body attached to the head,  compared to controls with non- 
immune IgG,  or anti-fluorescyl  antibodies  incubated  with 
unmodified myosin. Unambiguous localization of antigenic 
sites in the myosin head is not easy, however, because of the 
similarity in size between the head region and antibody, and 
the difficulty in defining the point of attachment of the anti- 
body to the head. In favorable complexes, the trinodular ap- 
pearance  of the  antibody  helps  to  distinguish  it  from the 
rounder,  slightly smaller myosin head.  Moreover, when the 
antibody is bound directly at the junction of the head with 
the rod,  its attachment site is more readily visualized than 
when it binds away from the junction. Nevertheless, only by 
inspecting a  large number of such complexes is it possible 
to determine  where a  particular antibody is binding in the 
myosin head. A montage of some typical images is shown in 
Figs.  7  and 8. 
When anti-fluorescyl IgG was added to myosin which was 
fluorescein-labeled at either Cys 177 of alkali  1 or Cys 136 
of alkali  2  light  chain,  the bound  antibody  was  most fre- 
quently  seen  at  some distance  from the head/rod junction 
Katoh and Lowey  Mapping the Light Chains of Myosin  1555 Figure 7. Gallery of  electron micrographs of antibody-myosin  com- 
plexes. (A) Anti-fluorescyl  antibody complexed  with myosin  whose 
alkali light chain was exchanged  with FI-A2. (B) Anti-A2 antibody 
complexed  with native myosin. The arrows point to the attached an- 
tibody. Note that the antibody binds to a site removed from the 
head-rod junction in most of the images. Bar, 100 rim. 
(Fig. 7 a). In contrast, myosin which was labeled at Cys 125 
or Cys  154 of the LC2 light chain showed predominantly 
complexes in which the antibody was bound at or near the 
head/rod  junction (Fig. 8, a and b). Localization experiments 
using antibodies  specific for the  NH2-terminal  regions of 
the two classes of light chains were also performed, even 
though sites mapped by these antibodies had been published 
previously (Winkelmann et al.,  1983;  Waller and Lowey, 
1985). In agreement with the earlier work, antibody specific 
for the NH2-terminal  portion of A2 was bound distal to the 
junction (Fig. 7 b),  whereas monoclonal antibody specific 
for the NH2 terminus of LC2 bound at the junction (Fig. 8 
c). Given the large uncertainty in mapping specific sites in 
the myosin head by immunoelectron microscopy, it was con- 
sidered important to use the amino-specific antibodies as 
controls for the COOH-terminal localizations. After mea- 
suring the point of attachment of the different types of anti- 
bodies to the myosin head, it became clear that two locations 
were  favored:  Both  the  COOH-  and  the  NH2-terminal 
regions of the alkali 2 light chain were 80-90 A  from the 
head/rod junction (Fig. 9, a and b), whereas the ends of the 
LC2 chain were mapped predominantly to the junction (Fig. 
9, c-e). Although the spread of data in the individual histo- 
grams is broad, particularly when the antibody binds to the 
middle of the head, it is possible to conclude that the light 
chains are located in distinct regions of the myosin head, and 
do not lie parallel to each other. 
Discussion 
Electron microscope images of myosin contraste4 by metal 
shadowing have shown a pear-shaped head `o200 A in length 
connected to a rod-like tail (Lowcy et al.,  1969; Elliott and 
Offer, 1978). By negative staining it has been possible to see 
some substructure in the head; in particular, a large domain 
of `ol00 A which accounts for more than half of the mass 
of the head, and two smaller domains in the neck region 
(Walker and Trinick, 1988). Ever since the light chains were 
shown by hydrodynamic methods to  be  highly elongated 
structures, it has been assumed that they interact with the 
heavy chain and with each other along the length of the neck 
region (Wallimann et al.,  1982).  Our present findings sug- 
gest that the light chains may be more compact and more 
separated in their locations than previously envisaged. One 
might even speculate that the two domains in the neck region 
of the negatively stained molecules may include portions of the 
regulatory (LC2) and essential (alkali) light chains (Fig. 10). 
Both classes of light chains are considered highly asym- 
metric structures, with a length of`ol00 A based on a prolate 
ellipsoid  model  (Alexis  and  Gratzer,  1978; Stafford and 
Szent-Gy6rgyi, 1978). It is significant that the light chains, 
troponin C, and calmodulin all have a similar Stokes radius 
(,o24/~,), sedimentation coefficient ("ol.8 S), and molecular 
weight (`o18,000) (Dedman et al.,  1977).  Moreover, the ra- 
dius of gyration, a sensitive measure of the distribution of 
mass,  is  similar  (`o23  /Yt) for calmodulin (Seaton et  al., 
1985),  troponin C  (Hubbard  et al.,  1988),  and the light 
chains  (Mendelson,  R.,  personal  communication).  Since 
these proteins also have a high degree of sequence homology 
(Weeds and McLachlan, 1974; Collins, 1976), it follows that 
their three-dimensional structures are probably closely re- 
lated.  From recent crystallographic determinations of the 
structure of calmodulin (Babu et al.,  1985) and troponin C 
(Herzberg and James,  1985;  Sundaralingam et al.,  1985a) 
we know that these molecules have a dumbbell shape with 
an overall length of"o70/~. If we assume that the light chains 
have a similar shape and dimension, the problem arises of 
how to arrange the light chains in the myosin head so that 
their location is compatible with the available chemical and 
electron microscopic data. 
Cysteine residues 125 and 154 of the LC2 light chain, and 
Cys 177(136) of the alkali light chains, were labeled selec- 
tively with iodoacetamido fluorescein to map their positions 
in the myosin head. Anti-fluorescyl antibodies localized the 
thiols of LC2 at the head/rod junction, whereas the single 
thiol of alkali 2 was observed `o90 A distal to the junction. 
Despite the large standard deviation in the measurement, the 
position of the COOH-terminal cysteine of alkali 2  found 
The Journal of Cell Biology, Volume  109, 1989  1556 Figure 8.  Gallery of electron micrographs of antibody-myosin complexes. (A) Anti-fluorescyl antibody complexed with myosin whose 
LC2 light chain was exchanged with FI-LC2 and (B) with DNS-LC2-F1. (C) Anti-LC2 (7C10) antibody complexed with native myosin. 
The arrows point to the attached antibody. Note that the antibody binds at the head-rod junction in most of the images. Bar, 100 nm. 
here agrees well with an earlier mapping study using avidin- 
biotin as a probe (Yamamoto et al.,  1985) and is consistent 
with  distances  estimated by  fluorescence energy  transfer 
(Marsh and Lowey, 1980).  The wide separation between the 
COOH-terminal regions of the two types of light chains was 
unexpected since one had usually imagined them to lie in an 
extended,  if  somewhat  staggered,  colinear  arrangement 
(Waller  and  Lowey,  1985).  Instead,  the  COOH-terminal 
regions of the chains were found in the same locations as the 
NH2-terminal regions mapped here and in previous studies 
(Winkelmann et al.,  1983;  Winkelmann and Lowey, 1986; 
Tokunaga et al.,  1987b). 
Can these locations be reconciled with a calmodulin-like 
structure for the light chains? Although the length of cal- 
modulin is *65  A, the COOH and NH2 termini of the chain 
are only separated by •40  A in the crystal structure. Under 
conditions where the molecule is bent at the central helix, 
the terminal regions of the chain can approach to within 20 
/~ or less of each other (Persechini and Kretsinger,  1988; 
Heidorn and Trewhella, 1988).  It is therefore reasonable to 
suggest that the structure of the light chains may resemble 
two globular domains connected by a flexible central helix 
(Sundaralingam et al., 1985b).  When the LC2 light chain is 
associated with the myosin heavy chain,  it may assume a 
more compact configuration than when it exists free in solu- 
tion in the absence of divalent cations (Alexis and Gratzer, 
1978).  An attempt was made to visualize the light chains 
directly by complexing them with antibodies specific for the 
amino and carboxyl ends of the chain (Fig.  6).  Antibody 
molecules were linked together by bivalent light chains in the 
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Figure  9.  Histograms  show- 
ing the  location of antibody- 
binding sites in the NH2- and 
COOH-terminal regions of the 
A2  and  LC2 light chains  on 
the  myosin  head.  Measure- 
ments were made on enlarged 
images of the antibody-myo- 
sin complex from the center of 
the  head-rod junction  along 
the length of the head to the 
midpoint of the attached anti- 
body.  Arrows  indicate  mean 
values normalized to a length 
of 20 nm for the myosin head. 
A, amino-terminal region 1-8 
of A2, 8 +  4 nm (n  =  120); 
B, Cys 136 of A2, 9  +  5 nm 
(n =  165); C, amino-terminal 
region 17-51 of LC2, 0 +  2.5 
nm (n =  128); D, Cys 125 of 
LC2, 0 +  2.5 nm (n =  157); 
E, Cys 154 of LC2, 0  +  2.5 
nm (n  =  188). 
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Figure 10. Schematic diagram of the myosin head showing the ap- 
proximate positions of the epitopes for the NH2- and COOH-ter- 
minal regions of the alkali and regulatory (LC2) light chains. The 
shape of the light chains is assumed to resemble the dumbbell struc- 
ture  found  for  homologous  Ca2+-binding proteins  (see  Discus- 
sion), but this is purely speculative. The large experimental error 
inherent in the mapping technique precludes a definitive assignment 
for the orientation  of the light chains,  but based on the available 
data,  we  favor the  NH2  termini  pointing  toward the  head-rod 
junction. 
form of cyclic dimers, trimers, and tetramers, similar to the 
images observed by Valentine  and Green (1967)  for their 
hapten/antibody complexes. Although the resolution is too 
poor to assign a definitive value, the results are more compat- 
ible with a dimension of ~70/~ for the light chains than one 
>100 A. 
A  globular  structure  for the  COOH-terminal  region  of 
LC2 is consistent with the observation that a disulfide bond 
is readily formed between Cys 125 and Cys 154 (Minowa et 
al.,  1983).  Moreover,  a  compact  structure  for  the  NH2- 
terminal portion of the chain is suggested by the localization 
of several monoclonal antibodies, whose specificities range 
from the  NH2-terminal trimethylalanine (Tokunaga et al., 
1987b)  to  an  epitope  including  residue  35  (Reinach  and 
Fischman, 1985) at the head/rod junction. Globular domains 
are also indicated by an c~-helix content of "~35 % for LC2 
(Holt and Lowey, 1975) compared to a value between 40% 
and 50%  for troponin  C  and calmodulin  (Dedman et al., 
1977). 
If we adopt a calmodulin-like structure as a reasonable ap- 
proximation for both classes of light chains (see Carboni et 
al., 1988 for a myosin-like 100-kD subunit that binds several 
molecules of calmodulin), then two such subunits, with some 
bending and overlap of domains, could be accommodated in 
the neck region of myosin and still be consistent with the 
electron microscopic mapping studies (Fig.  10).  The diffi- 
culty with such a model is that some of the chemical cross- 
linking data are difficult to reconcile with light chains that 
don't span a greater portion of the head.  Using photolabile 
bifunctional cross-linkers attached to the sulfhydryl residue 
of a number of regulatory light chains, it was concluded that 
the  essential  (alkali)  and  chemically  modified  regulatory 
light chains overlap by more than half of their length and lie 
in close proximity to each other in the myosin molecule (Wal- 
limann et al.,  1982).  Although there is enough uncertainty 
in the mapping data to accommodate these studies, it is diffi- 
cult to see how one can also fit in photolabeling experiments 
which implicate the essential light chain in the active site of 
smooth muscle myosin (Okamoto et al.,  1986). The ATPase 
site has been localized *50 A from the tip of the myosin head 
(Tokunaga et al.,  1987a), or --140/~ from the COOH-ter- 
minal end of S1. The finding that the essential light chain of 
scallop myosin can be cross-linked to Cys 125/154 of chicken 
LC2 implies that some portion of the essential light chain 
must extend to the vicinity of the head/rod junction. But the 
light chain would then have to be at least 150/~ long to bridge 
that great a distance. 
These disparate data lead one to conclude that either the 
light chains of different muscle types occupy unique  loca- 
tions in the myosin head, despite the high degree of sequence 
homology, or that there may be sufficient motion of the light 
chains to permit cross-linking between subunits that are on 
average spatially distant (Chantler and Bower,  1988). Some 
evidence for a relative movement between the essential and 
regulatory light chains has been obtained for molluscan mus- 
cles (Hardwicke et al.,  1983).  There is also an extensive 
literature on cross-linking of different regions of the heavy 
chain,  the principal conclusion of which  is that  so-called 
heavy chain domains may undergo  substantial  movements 
under different experimental conditions (see review by Vi- 
bert and Cohen,  1988). 
The advantage of using a fluorescent probe to label sulf- 
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and electron microscopy can be applied to the analysis of the 
myosin head. Until a crystallographic structure of S1 is avail- 
able  (Rayment and Winkelmann,  1984),  electron micros- 
copy is the only direct means to visualize the sites of interest, 
although one must recognize that the resolution of rotary- 
shadowed myosin/antibody complexes is low. By averaging 
the images using correlation methods, it may be possible to 
raise the resolution to a level where more structural informa- 
tion is available (Vibert, 1988). Avidin has been a very useful 
probe in mapping studies of the myosin head, because of the 
high affinity of avidin for biotinylated myosin (~10 ~5 M-l). 
However,  anti-fluorescyl antibodies of affinities  >101° M -t 
can be prepared  (Kranz et al.,  1982),  and their ability to 
quench the fluorescence of fluorescein offers a unique oppor- 
tunity to characterize the reactivity of the labeled sites. 
Fluorescein  is  most  widely  used  as  a  probe  in  spec- 
troscopic studies.  Techniques such as fluorescence energy 
transfer  have the advantage of being able  to measure dis- 
tances in the 10-60-/~ range with an error of no greater than 
20%, but only relative distances between two sites can be ob- 
tained. However, the spectroscopic approach does have the 
ability to detect changes accompanying dynamic processes 
such as ATP hydrolysis and actin activation. If, in fact, rear- 
rangement of the light chains and/or heavy chain domains 
takes place during contraction, it may indeed be necessary 
to use such a combination of optical and microscopic tech- 
niques to localize the reactive sites in myosin as the molecule 
undergoes its different conformational transitions. 
We wish to thank Dr. D. A. Winkelmann for advice on the immunoelectron 
microscopy, and Dr. G. Ashiba for assistance in the analysis of the histo- 
grams. T. Katoh appreciates the continuous encouragement given him by 
Drs.  G.  Ashiba and M.  Titus. 
This work was supported by grants from National  Institutes of Health 
(R37AR17350),  National Science Foundation (DMB86-17108),  and Mus- 
cular Dystrophy Association  to S.  Lowey. 
References 
Adelstein, R. S., and E. Eisenberg.  1980. Regulation and kinetics of the actin- 
myosin-ATP  interaction. Annu.  Rev. Biochem. 49:921-956. 
Alexis,  M. N., and W. B. Gratzer.  1978. Interaction of skeletal myosin light 
chain with calcium ions. Biochemistry.  17:2319-2325. 
Babu, Y. S., J. S. Sack, T. J. Greenhough, C. E. Bugg, A. R. Means, and W. J. 
Cook.  1985. Three-dimensional  structure  of calmodulin.  Nature  (Lond.). 
315:37-40. 
Bradford,  M. M.  1976. A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye bind- 
ing. Anal.  Biochem.  72:248-254. 
Carboni, J. M., K. A. Conzelman, R. A. Adams, D. A. Kaiser, T. D. Pollard, 
and M. S. Mooseker.  1988. Structural and immunological characterization 
of the  myosin-like  l l0-kD  subunit  of the  intestinal  microvillar  l l0K- 
calmodulin  complex:  evidence  for discrete  myosin head and calmodulin- 
binding domains. J.  Cell Biol. 107:1749-1757. 
Chantler, P. D., and S. M. Bower. 1988. Cross-linking between translationally 
equivalent sites on the two heads of myosin. J. Biol. Chem. 263:938-944. 
Collins, J. H.  1976. Homology of myosin DTNB light chain with alkali light 
chains,  troponin C and parvalbumin.  Nature  (Lond.).  259:699-700. 
Cooke, R., M. S. Crowder,  C. H. Wen&, V. A. Barnett, and D. D. Thomas. 
1984. Muscle cross-bridges:  do they rotate? In Contractile Mechanisms in 
Muscle. G. H. Pollack and H. Sugi, editors. Plenum Publishing Corp., New 
York.  413-427. 
Dedman, J. R., J. D. Potter, R. L. Jackson, J. D. Johnson, and A. R. Means. 
1977.  Physicochemical  properties  of rat  testis  Ca2+-dependent regulator 
protein of cyclic nucleotide phosphodiesterase.  J.  Biol. Chem. 252:8415- 
8422. 
Degani, Y., and A. Patchornik.  1974. Cyanylation of  sulfbydryl groups  by 2-ni- 
tro-5-thiocyanobenzoic  acid. High-yield modification and cleavage of pep- 
tides at cysteine residues.  Biochemistry.  13:1-1 I. 
Dreizen,  P., and L. C. Gershman.  1970. Relationship of structure to function 
in myosin. Salt denaturation and recombination experiments. Biochemistry. 
9:1688-1693. 
EIliott, A., and G. Offer.  1978. Shape and flexibility of the myosin molecule. 
J.  MoL  Biol. 123:505-519. 
EIIman,  G.  L.  1959, Tissue sulthydryl  groups.  Arch.  Biochem.  Biophys, 
82:70-77. 
Flicker, P. F., T. Wallimann, and P. Vibert. 1983. Electron microscopy of scal- 
lop myosin. Location of regulatory light chains. J. Mol. Biol. 169:723-741. 
Hardwicke,  P. M. D., T. Wallimann, and A. G. Szent-Gy6rgyi.  1983. Light- 
chain  movement and  regulation  in scallop  myosin.  Nature  (Lond.).  301: 
478-482. 
Harrington,  W. F.  1979. On the origin of the contractile force in skeletal mus- 
cle.  Proc. Natl. Acad.  Sci. USA. 76:5066-5070. 
Heidorn, D. B., and J. Trewhella.  1988. Comparison of the crystal and solution 
structures of calmodulin and troponin C. Biochemistry.  27:909-915. 
Henry, G. D., I. P. Trayer, S. Brewer, and B. A. Levine. 1985. The widespread 
distribution  of ~-N-trimethylalanine  as the N-terminal amino acid of light 
chains from vertebrate striated muscle myosins. Eur. J. Biochem. 148:75-82. 
Herzberg, O., and M. N. G. James.  1985. Structure of the calcium regulatory 
muscle  protein  troponin-C  at  2.8  /~  resolution.  Nature  (Lond.).  313: 
653-659. 
Holt, J.  C., and S.  Lowey.  1975. An immunological approach to the role of 
the low molecular weight subunits in myosin. 1. Physical-chemical and im- 
munological  characterization  of the  light chains.  Biochemistry.  14:4600- 
4609. 
Hubbard, S. R., K. O. Hodgson, and S. Doniach. 1988. Small-angle X-ray scat- 
tering investigation of the solution structure of troponin C. J. Biol. Chem. 
263:4151--4158. 
Hudson, E. W., and G. Weber.  1973. Synthesis and characterization  of two 
fluorescent sulfhydryl reagents.  Biochemistry.  12:4154-4161. 
Huxley, H. E., and M. Kress.  1985. Cross-bridge behavior during muscle con- 
traction. J.  Muscle Res.  Cell Motil.  6:153-161. 
Huxley,  H.  E.,  R.  M.  Simmons,  A.  R.  Faruqi,  M.  Kress,  J.  Bordas,  and 
M. H. J.  Koch.  1983. Changes  in the X-ray  reflections from contracting 
muscle during rapid mechanical transients and their structural implications. 
J.  Mol. Biol. 169:469-506. 
Hynes, T. R., S. M. Block, B. T. White, and J. A. Spudich.  1987. Movement 
of myosin fragments in vitro: domains involved in force production.  Cell. 
48:953-963. 
Kranz, D. M., J. N. Herron, and E. W. Voss, Jr. 1982. Mechanisms of ligand 
binding by monoclonal anti-fluorescyl antibodies. J. BioL Chem. 257:6987- 
6995. 
Laemmli, U. K.  1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage I"4. Nature  (Lond.). 227:680-685. 
Lopatin, D. E., and E. W. Voss, Jr.  1971. Fluorescein.  Hapten and antibody 
active-site probe.  Biochemistry.  10:208-213. 
Lowey, S. 1986. The structure of vertebrate muscle myosin. In Myology. A. G. 
Engel and B. Q. Banker, editors.  McGraw-Hill Inc., New York. 563-587. 
Lowey, S., and D. Risby.  1971. Light chains from fast and slow muscle myo- 
sins. Nature  (Lond.). 234:81-85. 
Lowey, S., H. S. Slayter, A. G. Weeds, and H. Baker.  1969. Substructure of 
the myosin molecule. I. Subfragments of myosin by enzymic degradation. 
J.  Mol. Biol. 42:1-29. 
Margossian, S. S., and S. Lowey. 1982. Preparation of myosin and its subfrag- 
ments from rabbit skeletal muscle. Methods Enzymol.  85:55-71. 
Marsh,  D. J., and S.  Lowey.  1980. Fluorescence energy transfer  in myosin 
sabfragment-l. Biochemistry.  19:774-784. 
Matsuda, G.  1983. The light chains of muscle myosin: Its structure,  function, 
and evolution. Adv.  Biophys.  16:185-218. 
Minowa,  O., S.  Matsuda,  and K.  Yagi.  1983. Ca2+-induced conformational 
changes of 20,000 dalton light chain of vertebrate striated muscle myosins. 
J.  Biochem. 94:25-35. 
Okamoto, Y., T. Sekine, J. Grammer, and R. G. Yount.  1986. The essential 
light chains constitute part of  the active site of smooth muscle myosin. Nature 
(Lond.). 324:78-80. 
Petrie,  W.  T., and S.  V. Perry.  1970. An electrophoretic  study of the low- 
molecular-weight components of myosin. Biochem. J.  119:31-38. 
Perrie,  W. T., L. B. Smillie, and S. V. Perry.  1973. A phosphorylated light- 
chain component of myosin from skeletal muscle. Biochem. J. 135:15 I-  164. 
Persechini,  A., and R. H. Kretsinger.  1988. The central helix of calmodulin 
functions as a flexible tether. J.  Biol. Chem. 263:12175-12178. 
Rayment, I., and D. A. Winkelmann.  1984. Crystallization of myosin subfrag- 
ment  1. Proc.  Natl. Acad.  Sci. USA. 81:4378-4380. 
Reinach, F. C., and D. A. Fischman.  1985. Recombinant DNA approach for 
defining the primary structure of monoclonal antibody epitopes. J. Mol. Biol. 
181:411-422. 
Seaton,  B.  A.,  J.  F.  Head,  D.  M.  Engelman,  and  F.  M.  Richards.  1985. 
Calcium-induced increase in the radius of  gyration and maximum dimension 
of calmodulin  measured  by  small-angle  X-ray  scattering.  Biochemistry. 
24:6740-6743. 
Sellers, J. R., M. D. Pato, and R. S. Adelstein. 1981. Reversible phospboryla- 
tion of smooth muscle myosin,  heavy meromyosin and platelet myosin, jr. 
Biol.  Chem. 256:13137-13142. 
Silberstein, L., and S. Lowey. 1981. Isolation and distribution of myosin isoen- 
zymes in chicken pectoralis muscle. J.  Mol. Biol. 148:153-189. 
Sivaramakrishnan, M., and M. Burke. 1982. The free heavy chain of vertebrate 
Katoh and Lowey Mapping the Light  Chains of Myosin  1559 skeletal myosin subfragment 1 shows full enzymatic activity. J. Biol.  Chem. 
257:1102-1105. 
Stafford,  W. F., and A. G. Szent-Gy6rgyi. 1978. Physical characterization of 
myosin light chains. Biochemistry.  17:607-614. 
Sundaralingam, M., R. Bergstrom, G. Strasburg, S. T. Rao, P. Roychowd- 
hury, M. Greaser, and B. C. Wang. 1985a. Molecular structure of troponin 
C  from chicken skeletal muscle at 3-angstrom resolution. Science (Wash. 
DC). 227:945-948. 
Sundaralingam, M., W. Drendel, and M. Greaser.  1985b. Stabilization  of the 
long central helix of troponin C by intrahelical  salt bridges between charged 
amino acid side chains. Proc.  Natl.  Acad.  Sci.  USA. 82:7944-7947. 
Szent-Gy6rgyi, A. G., and P. D. Chantler. 1986. Control of contraction by my- 
osins. In Myology. A. G. Engel and B. Q. Banker, editors. McGraw-HiU 
Inc., New York. 589-612. 
Szent-Gy6rgyi, A. G., E. M. Szentkiralyi, and J. Kendrick-Jones. 1973. The 
light chains of scallop myosin as regulatory subunits. J. Mol. Biol. 74:179- 
203. 
Tokunaga, M., K. Sutoh, C. Toyoshima, and T. Wakabayashi. 1987a.  Loca- 
tion of the ATPase site of myosin determined by three-dimensional electron 
microscopy. Nature (Lond.).  329:635-638. 
Tokunaga, M., M. Suzuki, K. Saeki, and T. Wakabayashi. 1987b. Position of 
the amino terminus of myosin light chain I and light chain 2 determined by 
electron microscopy with monoclonal antibody. J. Mol. Biol.  194:245-255. 
Tyler, J. M., and D. Branton. 1980. Rotary shadowing of extended molecules 
dried from glycerol. J.  Ultrastruct.  Res.  71:95-102. 
Valentine, R. C., and N. M. Green. 1967. Electron microscopy of an antibody- 
hapten complex. J. Mol.  Biol.  27:615-617. 
Vibert, P. J. 1988. Domain structure of the myosin  head in correlation-averaged 
images of shadowed molecules. J.  Muscle Res.  Cell Motil.  9:147-155. 
Vibert, P., and C. Cohen. 1988. Domains, motions and regulation in the myosin 
head. J.  Muscle Res.  Cell Motil.  9:296-305. 
Vibert, P., E. Szentkiralyi,  P. Hardwicke, A. G. Szent-Gy6rgyi, and C. Cohen. 
1986.  Structural models for the regulatory switch of myosin. Biophys.  J. 
49:131-133. 
Wagner, P. D.  1981.  Formation and characterization of myosin hybrids con- 
mining light chains and heavy chains from different muscle myosins. J. Biol. 
Chem.  256:2493-2498. 
Wagner, P. D., and E. Giniger. 198 i. Hydrolysis of ATP and reversible bind- 
ing to F-actin by myosin heavy chains free of all light chains. Nature (Lond.). 
292:560-562. 
Wagner, P. D., and A. G. Weeds. 1977. Studies on the role of myosin alkali 
light chains. Recombination and hybridization of light chains and heavy 
chains in subfragment-I preparations. J.  Mol.  Biol.  109:455-473. 
Walker,  M.,  and J.  Trinick.  1988.  Visualization of domains in native and 
nucleotide-trapped  myosin heads by negative staining. J.  Muscle Res.  Cell 
Motil.  9:359-366. 
Waller, G. S., and S. Lowey. 1985. Myosin subunit interactions. Localization 
of the alkali  light chains. J.  Biol.  Chem.  260:14368-14373. 
Wallimann, T., P. M. D. Hardwicke, and A. G. Szent-Gy6rgyi. 1982. Regula- 
tory and essential light-chain interactions in scallop myosin. II. Photochemi- 
cal cross-linking of regulatory and essential light-chains by heterobifunc- 
tional  reagents. J.  Mol.  Biol.  156:153-173. 
Weeds, A. G., and A. D. McLachlan.  1974.  Structural  homology of myosin 
alkali  light chains, troponin C  and carp calcium binding protein.  Nature 
(Lond.).  252:646-649. 
White, H. D. 1982. Special  instrumentation and techniques for kinetic  studies 
of contractile systems. Methods  Enzymol.  85:698-708. 
Wikman-Coffelt, J., S. Srivastava, and D. T. Mason.  1979.  Biochemie.  61: 
1309-1314. 
Winkelmann, D. A., and S. Lowey. 1986. Probing myosin bead structure with 
monoclonai antibodies. J. Mol.  Biol.  188:595-612. 
Winkelmann, D. A., S. Lowey, and J. L. Press. 1983. Monoclonal antibodies 
localize changes on myosin heavy chain isozymes during avian myogenesis. 
Cell.  34:295-306. 
Yamamoto, K., M.  Tokunaga, K.  Sutoh, T.  Wakahayashi, and T.  Sekine. 
1985. Location of the SH group of the alkali light chain on the myosin head 
as revealed by electron microscopy. J.  Mol.  Biol.  183:287-290. 
The Journal of Cell Biology, Volume 109,  1989  1560 